Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00202839
Show Display Options
Rank Status Study
1 Completed
Has Results
Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Ribavirin

Study has passed its completion date and status has not been verified in more than two years.